Nitric oxide dependent-response, calculated as the difference between pEC₅₀-values of concentration response curves incubated with indomethacin and indomethacin/L-NAME respectively – ΔpEC₅₀; controls (n = 10), ESRD (n = 11); p = 0.15.

<p>Nitric oxide dependent-response, calculated as the difference between pEC₅₀-values of concentration response curves incubated with indomethacin and indomethacin/L-NAME respectively – ΔpEC₅₀; controls (n = 10), ESRD (n = 11); p = 0.15.</p

Association between S-Phosphate and EDH-like relaxation (pEC₅₀) in controls (r = −0.66; p<0.05) and ESRD (r = −0.30; p = 0.18), Pearson one-tailed correlation.

<p>Association between S-Phosphate and EDH-like relaxation (pEC₅₀) in controls (r = −0.66; p<0.05) and ESRD (r = −0.30; p = 0.18), Pearson one-tailed correlation.</p

Hemodynamics in patients with end stage renal disease (ESRD) and healthy controls.

<p>Systemic vascular resistance (SVR).</p><p>Data are mean±SEM; * p<0.05; ^§ n = 4; ^# n = 10.</p

Concentration-response relaxation curves to acetylcholine in arteries from healthy controls and patients with end stage renal disease.

<p>A: Endothelium dependent vasodilatation; p = ns. B: Endothelium-derived hyperpolarisation-like relaxation in the presence of indomethacin and L-NAME; p = ns.</p

Early Economic Assessment of Faecal Microbiota Transplantation for Patients with Urinary Tract Infections Caused by Multidrug-Resistant Organisms

   The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. </p

Uremic symptoms at dialysis initiation (DI) in 446 patients with CKD5 in percent.

<p>Symptoms were present in 83% of patients, the most common being fatigue (44%), nausea (24%) and anorexia (22%). Black bars: primary symptoms; hatched bars: secondary or other symptoms.</p

Primary reasons for chronic dialysis initiation (DI) in 446 patients with CKD5.

<p>Clinical reasons accounted for 63% and biochemical reasons for 37% of all DI. The 12 most common motivations accounted for 91% of all DI prescriptions, “fatigue” being most common (22%) among clinical motivations, and “low GFR” (13%) most common among DI based on biochemical grounds.</p

Correlations to renal diagnosis, patient sex and patient age.

<p>No. patients (%).</p